These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15558044)
1. Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants. Gyger M; Rosenberg A; Shamy A; Hercz A; Caplan S; Sebag IA; Brisson ML; Roy DC Bone Marrow Transplant; 2005 Jan; 35(2):201-3. PubMed ID: 15558044 [No Abstract] [Full Text] [Related]
2. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease. Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954 [TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
6. Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients. Akhtari M; Langston AA; Waller EK; Gal AA Bone Marrow Transplant; 2009 Jan; 43(2):155-8. PubMed ID: 18794871 [TBL] [Abstract][Full Text] [Related]
7. Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older. Gupta V; Daly A; Lipton JH; Hasegawa W; Chun K; Kamel-Reid S; Tsang R; Yi QL; Minden M; Messner H; Kiss T Biol Blood Marrow Transplant; 2005 Oct; 11(10):764-72. PubMed ID: 16182177 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelium as 'novel' target of graft-versus-host disease. Tichelli A; Gratwohl A Best Pract Res Clin Haematol; 2008 Jun; 21(2):139-48. PubMed ID: 18503982 [TBL] [Abstract][Full Text] [Related]
10. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Strober S Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036 [TBL] [Abstract][Full Text] [Related]